SUNNYVALE, Calif., April 13 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced
that it will report results for its third quarter fiscal year 2009, ending
March 28, 2009 on Tuesday, May 5, 2009 after the market closes.
A conference call to review the results will begin at 2:00 p.m. PDT/ 5:00
p.m. EDT and will be hosted by Euan S. Thomson, Ph.D., president and chief
executive officer and Derek Bertocci, senior vice president and chief
financial officer.
The conference call dial-in numbers are 1-866-379-2019 (USA) or
1-706-634-1525 (International), Conference ID: 90985949. In addition, a
dial-up replay of the conference call will be available beginning May 5, 2009
at 5:00 p.m. PDT/8:00 p.m. EDT and ending on May 8, 2009. The replay
telephone number is 1-800-642-1687 (USA) or 1-706-645-9291 (International),
Conference ID: 90985949
A live webcast of the call will also be available from the Investor
Relations section of the corporate Web site at http://www.accuray.com. A
webcast replay can be accessed on the corporate Web site beginning Tuesday,
May 5, 2009 at approximately 5:00 p.m. PDT/8:00 p.m. EDT. The replay will
remain available until Accuray announces its results for the fourth quarter of
fiscal 2009, ending June 27, 2009.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a
global leader in the field of radiosurgery dedicated to providing an improved
quality of life and a non-surgical treatment option for those diagnosed with
cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery
System, which extends the benefits of radiosurgery to include extracranial
tumors, including those in the spine, lung, prostate, liver and pancreas. To
date, the CyberKnife System has been used to treat more than 60,000 patients
worldwide and currently more than 155 systems have been installed in leading
hospitals in the Americas, Europe and Asia. For more information, please visit
www.accuray.com.
SOURCE Accuray Incorporated
04/13/2009
CONTACT: Investors, Tom Rathjen, Vice President of Investor Relations,
+1-408-789-4458, trathjen@accuray.com, or Media, Stephanie Tomei, Senior
Manager of Public Relations, +1-408-789-4234, stomei@accuray.com, both of
Accuray
Web Site: http://www.accuray.com
